Predictive Technology Group, Inc. (PRED) Announces Acquisition of US Patent Application for Method for Treating Patients with Stem Cells "Cleaned" via CRISPR Genetics Investing
Coherus BioSciences Announces Positive Topline 24-Week Treatment Phase Three Results for CHS-1420 (HUMIRA® Biosimilar Candidate) in Patients with Psoriasis Pharmaceutical Investing
Helius Medical Technologies Announces Launch of Fifth Site for Pivotal Mild to Moderate Traumatic Brain Injury Clinical Trial Medical Device Investing
Oncobiologics Issues Remaining Senior Secured Notes and Warrants – Raising an Aggregate $10.0 Million Biotech Investing
Cytori to Expand Scleroderma Focus to Broader Hand Therapy Franchise Under the Habeo™ Cell Therapy Brand Biotech Investing
Biocept Secures In-Network Provider Agreement with Blue Cross Blue Shield of Texas Medical Device Investing
BioCryst Receives Health Canada Approval for RAPIVAB® for the Treatment of Influenza Life Science Investing
BriaCell and BriaPro to Present Preclinical Anti-Cancer Activity and Immunotherapy Findings at SITC 2026
